We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Sugar Found in Red Meat Causes Chronic Inflammation in Human-Like Mouse Model

By LabMedica International staff writers
Posted on 06 Jan 2015
Print article
Image: N-Glycolylneuraminic acid (Neu5Gc) (Photo courtesy of Wikimedia Commons).
Image: N-Glycolylneuraminic acid (Neu5Gc) (Photo courtesy of Wikimedia Commons).
Chronic inflammation in humans, which has been linked to tumor formation as well as development of other syndromes such as atherosclerosis and type II diabetes, may be a response to red meat in the diet that contains the sugar N-Glycolylneuraminic acid (Neu5Gc).

Humans differ from other mammals by being unable to synthesize Neu5Gc, as the human CMAH gene has been irreversibly mutated and produces an inactive form of the enzyme CMP-N-acetylneuraminic acid hydroxylase, which is the enzyme responsible for synthesizing CMP-Neu5Gc from CMP-N-acetylneuraminic (CMP-Neu5Ac) acid. Even though Neu5Gc cannot be produced by humans, it has been found in human cancers and fetal samples, which suggests that molecules of Neu5Gc enter human pathways through external sources, such as diet. Some researchers have suggested that eating red meat could lead to inflammation if the body’s immune system constantly generates antibodies against consumed animal Neu5Gc, a foreign molecule.

To study the relationship between red meat consumption and tumor development, investigators at the University of California, San Diego (USA) genetically engineered a mouse model to mimic the human condition by lacking Neu5Gc.

The investigators first evaluated the Neu5Gc content of various foods and showed that red meats were particularly rich in orally bioavailable Neu5Gc. They then fed this form of Neu5Gc to the human-like Neu5Gc-deficient mice. Results published in the December 29, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) revealed that when such mice were challenged with anti-Neu5Gc antibodies, they developed evidence of systemic inflammation. Long-term exposure to this combination resulted in a significantly higher incidence of carcinomas (five-fold increase) and an association with Neu5Gc accumulation in the tumors.

“Until now, all of our evidence linking Neu5Gc to cancer was circumstantial or indirectly predicted from somewhat artificial experimental setups,” said senior investigator Dr. Ajit Varki, professor of medicine and cellular and molecular medicine at the University of California, San Diego. “This is the first time we have directly shown that mimicking the exact situation in humans — feeding non-human Neu5Gc and inducing anti-Neu5Gc antibodies — increases spontaneous cancers in mice.”

“The final proof in humans will be much harder to come by,” said Dr. Varki. “But on a more general note, this work may also help explain potential connections of red meat consumption to other diseases exacerbated by chronic inflammation, such as atherosclerosis and type II diabetes. Of course, moderate amounts of red meat can be a source of good nutrition for young people. We hope that our work will eventually lead the way to practical solutions for this catch-22.”

Related Links:

University of California, San Diego


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.